Skip to content

Clinical trials

Phase 3 Immune System Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 3 Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20151
20162
20171
20183
20201
20222
20233
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting3
Recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novartis Pharmaceuticals2
Pfizer2
Takeda2
Viatris Innovation GmbH2
Adienne SA1
Ariad Pharmaceuticals1
Baxalta now part of Shire1
Biogen1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases20
Autoimmune Diseases11
Connective Tissue Diseases6
Lupus Erythematosus, Systemic6
Hypersensitivity5
Hematologic Diseases4
Hypersensitivity, Immediate4
Asthma2
Blood Platelet Disorders2
Bronchial Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.